Short @324 if support is tough buy @334. Market doesn't matter in this situation. But don't go against the scrip trend.
评论:
Don't short now 100% buy
Sub: Glenmark receives approval from the regulator (DCGI) to conduct Clinical Trials in
India on Favipiravir Antiviral tablets for COVID-19 patients
Sub: Glenmark receives approval from the regulator (DCGI) to conduct Clinical Trials in
India on Favipiravir Antiviral tablets for COVID-19 patients
Dapagliflozin and Saxagliptin Tablets, 10 mg/5 mg.... Expected huge price rise...